Compare IQIYI Inc - ADR (IQ) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IQIYI Inc - ADR vs Pfizer Inc — how do they compare? IQIYI Inc - ADR trades at $1.02 (market cap $974.67M), while Pfizer Inc trades at $28.28 (market cap $158.56B). The key difference: Pfizer Inc is far larger — about 162.7× IQIYI Inc - ADR's market cap, and Pfizer Inc pays a 6.18% dividend while IQIYI Inc - ADR pays none. Which is the better fit depends on your goals — on Pluang, investors hold IQIYI Inc - ADR for 55 Days and Pfizer Inc for 158 Days on average.
| IQ | PFE | |
|---|---|---|
Market Cap | $974.67M | $158.56B |
Volume | 4,964,108 | 44,138,282 |
Sector | Media | Health |
52-Week High | $2.35 | $29.02 |
52-Week Low | $0.86 | $23.67 |
Typical Hold Time | 55 Days | 158 Days |
Enterprise Value | $2.47B | $210.06B |
Dividend Yield | — | 6.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
iQIYI (IQ) trades at $1.01, down 0.49% with bearish technical signals. The company reported Q2 2026 revenue of RMB 6.3 billion with a narrowed operating loss, while full-year 2025 showed revenue decline to $27.29B and net loss of $206M. Analyst consensus is mixed with 50% buy ratings amid ongoing business transformation toward AI-driven content production.
The outlook remains challenging with streaming revenue pressure, though AI initiatives show promise. Key risks include competitive threats and execution uncertainty. Wall Street maintains cautious optimism with 11 buy ratings but requires evidence of sustainable profitability turnaround.
Pfizer (PFE) trades at $27.82, down 0.64% on the day, with a bullish technical signal from moving averages and oversold RSI levels. The company reported revenue of $62.58B in 2025 with a net income margin of 6.8%, and has beaten earnings estimates for three consecutive quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline, positioning for a catalyst-rich 2026.
The stock presents a value opportunity with a forward P/E of 36.61 and consensus price target of $29.17, but faces risks from patent cliffs and volatile cash flows. Analyst sentiment is mixed with 40% buy ratings, while institutional outlook remains cautious amid earnings pressure and competitive threats in the pharma sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
